Table 1.
Characteristic | Value |
---|---|
Age (yr) [mean ± SD (range)] | 47.7 ± 11.9 (32–73) |
Male [n (%)] | 4 (36) |
Caucasian [n (%)] | 11 (100) |
Preexisting conditions [n (%)] | 6 (54) |
Osteoarthritis | 4 (36) |
Rheumatoid arthritis | 1 (9) |
Spondyloarthropathy | 1 (9) |
Distribution of arthritis [n (%)] | |
Monoarticular | 6 (54) |
Oligoarticular | 5 (46) |
Joint aspirated [n (%)] | |
Knee | 9 (82) |
Wrist | 1 (9) |
Elbow | 1 (9) |
Course of arthritis/joint effusion [n (%)] | |
Intermittent | 11 (100) |
Persistent | 0 (0) |
Time since onset of arthritis prior to consultation (days) [mean (range)] | 1051 (122–2555) |
History of erythema migrans rash [n (%)] | 1 (9) |
History of tick bite [n (%)] | 1 (9) |
Concurrent symptoms at time of consultation visit [n (%)] | |
Arthralgia | 11 (100) |
Subjective cognitive dysfunction | 6 (54) |
Fatigue | 4 (36) |
Myalgia | 2 (18) |
Prescribed antibiotic coursesa | |
Total no. of days of antibiotic therapy for seronegative patients [mean (range)] | 72 (10–165) |
Seronegative patients treated with oral antibioticsb [n (%)] | 10 (100) |
Duration (days) [mean (range)] | 53 (10–108) |
Patients treated with parenteral antibioticsc [n (%)] | 5 (45) |
Duration (days) [mean (range)] | 38 (2–70) |
Patients simultaneously receiving intravenous and oral antibiotics [n (%)] | 5 (45) |
Of the 10 seronegative patients.
Doxycycline, amoxicillin, clarithromycin, or azithromycin.
Ceftriaxone.